The Rising Cost of Lung Cancer Therapies: What Are the Global Implications?

Nursing Care’s Technological Patient-Care Transformation

IASLC SCLC Meeting Program, Faculty to Reflect the Field’s Pivotal, Recent Major Advances

The IASLC’s Spotlight on Screening

Valerie W. Rusch, MD, FACS

Thoughts on IMpower 150: Latest FDA Approval for Atezolizumab Misses the Mark

Cancer Research Innovator, Trailblazer, and Mentor Dr. Waun Ki Hong Dies

Ongoing Clinical Challenges: Defining Immunotherapy Benefit for Patients With NSCLC and Poor Performance Status

Dr. Fred R. Hirsch Departs IASLC CEO Role, Joins Mount Sinai Hospital

Prophylactic Cranial Irradiation in Locally Advanced NSCLC Falls Flat

FDA Approval Processes in the Era of Targeted Therapies: A Conversation with Dr. Richard Pazdur

Explaining IMpower132: An Interview with Dr. Vassiliki A. Papadimitrakopoulou